Diseases affecting vestibular system
Also known as: Vestibular disorder / Vestibular Disorders / Vestibular Function Disorder / Diseases, Vestibular / Vestibular Diseases / Vestibular Disease / Unspecified disorder of vestibular function, unspecified ear / Unspecified disorder of vestibular function / Disorder vestibular / Labyrinthine disorder (disorder) / Vestibular disorder NOS / Disorders of vestibular function / Vertigo labyrinthine / Vertigo of central origin / Vertigo CNS origin / Central Nervous System Origin Vertigo / Vertigo of central origin (disorder) / Labyrinthine disorder NOS / Labyrinthine disorders / Labyrinth Diseases / Labyrinthine disorder / Disorder labyrinthine
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00737 | Meclizine | A histamine H1 antagonist used to treat nausea, vomiting, and dizziness associated with motion sickness. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00737 | Meclizine | Histamine H1 receptor | target |
| DB00737 | Meclizine | Nuclear receptor subfamily 1 group I member 3 | target |
| DB00737 | Meclizine | Cytochrome P450 2D6 | enzyme |
| DB00737 | Meclizine | Serum albumin | carrier |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00166 | Lipoic acid | 0 | Withdrawn | 1 |
| DB09270 | Ubidecarenone | 0 | Withdrawn | 1 |
| DB00335 | Atenolol | 2 | Withdrawn | 1 |
| DB06637 | Dalfampridine | 2 | Withdrawn | 1 |
| DB00635 | Prednisone | 2 | Completed | 1 |
| DB00443 | Betamethasone | 4 | Terminated | 1 |
| DB00860 | Prednisolone | 4 | Terminated | 1 |
| DB06698 | Betahistine | Not Available | Unknown Status | 1 |